BRIDGEWAY CAPITAL MANAGEMENT, LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 62 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$217,978
-12.9%
149,300
+36.6%
0.01%
-16.7%
Q2 2023$250,297
+72.7%
109,300
-31.4%
0.01%
+50.0%
Q1 2023$144,963
+7.1%
159,3000.0%0.00%0.0%
Q4 2022$135,405
+4.2%
159,3000.0%0.00%
+33.3%
Q3 2022$130,000
-17.7%
159,3000.0%0.00%
-25.0%
Q2 2022$158,000
-39.5%
159,3000.0%0.00%
-20.0%
Q1 2022$261,000
-51.8%
159,300
-29.0%
0.01%
-50.0%
Q4 2021$541,000
-29.8%
224,300
+40.8%
0.01%
-33.3%
Q3 2021$771,000
+37.9%
159,300
-23.9%
0.02%
+50.0%
Q2 2021$559,000
-11.1%
209,300
+2.4%
0.01%
-16.7%
Q1 2021$629,000
+32.1%
204,300
+52.8%
0.01%
+20.0%
Q4 2020$476,000
-11.2%
133,7000.0%0.01%
-16.7%
Q3 2020$536,000
+47.3%
133,7000.0%0.01%
+71.4%
Q2 2020$364,000
+29.1%
133,7000.0%0.01%
+16.7%
Q1 2020$282,000
-61.2%
133,7000.0%0.01%
-40.0%
Q4 2019$727,000
+103.1%
133,700
+50.2%
0.01%
+150.0%
Q1 2019$358,000
+22.6%
89,000
+11.8%
0.00%0.0%
Q4 2018$292,000
-67.4%
79,600
-23.9%
0.00%
-55.6%
Q3 2018$897,000
-3.9%
104,600
+23.1%
0.01%0.0%
Q2 2018$933,000
-4.8%
85,0000.0%0.01%
-18.2%
Q1 2018$980,000
+11.2%
85,0000.0%0.01%
+22.2%
Q4 2017$881,000
-35.0%
85,0000.0%0.01%
-40.0%
Q3 2017$1,355,00085,0000.02%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders